Respiratory exercise device

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of a respiratory exercise device showing our new design;

FIG. 2 is a top plan view thereof;

FIG. 3 is a side elevation view thereof, the opposite side being a mirror image thereof;

FIG. 4 is a front elevation view thereof;

FIG. 5 is a rear elevation view thereof; and,

FIG. 6 is a bottom plan view thereof.

The broken lines that are immediately adjacent to the claimed areas depict the bounds of the claimed design while all other broken lines are directed to environment. The broken lines form no part of the claimed design.

Claims

The ornamental design for a respiratory exercise device, as shown and described.

Referenced Cited
U.S. Patent Documents
D303440 September 12, 1989 Campbell
7721729 May 25, 2010 Von Hollen
D713531 September 16, 2014 Way
D731050 June 2, 2015 Meyer
D760889 July 5, 2016 Evans
D778429 February 7, 2017 Engelbreth
D780249 February 28, 2017 Ramsthaler
D795431 August 22, 2017 Way
D795440 August 22, 2017 Way
20030234017 December 25, 2003 Pelerossi et al.
20080078383 April 3, 2008 Richards
20130273490 October 17, 2013 Way
20140150790 June 5, 2014 Meyer
20160038056 February 11, 2016 Johnson et al.
20160150998 June 2, 2016 Shiner et al.
20180228643 August 16, 2018 Goldstein
Foreign Patent Documents
2948137 November 2015 CA
WO-2004012577 February 2004 WO
2015120435 August 2015 WO
Other references
  • Hammacher Schlemmer. Link: https://www.hammacher.com/product/respiratory-exerciser?cm_cat=ProductSEM&cm_pla=AdWordsPLA&source=PRODSEM&gclid=EAlalQobChMlz9Swsaeb4AlVy4CfCh1pPA64EAQYBCABEglQJPD_BwE. Visited Feb. 1, 2019. The Respiratory Exerciser. (Year: 2019).
  • Abe Fumito, et al., Histone deacetylase inhibitors inhibit metastasis by restoring tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma, Oncotarget, vol. 8, No. 5, pp. 7572-7585, 2017.
  • Lindahl Lisa M., et al., Prognostic miRNA classifier in early-stage mycosis fungoides: Development and validation in a Danish nationwide study, Blood, published by the American Society of Hematology, Prepublished online Dec. 5, 2017, DOI: 10.1182/blood-2017-06-788950.
  • Marosvari Dora., et al., Altered MicroRNA Expression in Folliculotropic and Transformed Mycosis Fungoides, Springer-Pathol. Oncol. Res., 21:821-825, 2015.
  • Narducci MG., et al., MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sezary syndrome, Cell Death and Disease, 2, e151; Mcmillan Publishers Limited, 2011.
  • Ralfkiaer Ulrik., et al., MicroRNA Expression in Early Mycosis Fungoides Is Distinctly Different from Atopic Dermatitis and Advanced Cutaneous T-Cell Lymphoma, Anticancer Research, 34:7207-7218, 2014.
  • Sandoval Juan, et al., MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated MicroRNA in Cutaneous T-Cell Lymphpma, Journal of Investigative Dermatology, 2015, 135, 1128-1137, The Society of Investigative Dermatology, 2015.
Patent History
Patent number: D874006
Type: Grant
Filed: Dec 15, 2017
Date of Patent: Jan 28, 2020
Assignee: Aerofit.dk ApS (Birkerød)
Inventors: Christian Tulberg Poulsen (Birkerød), Tue Toft (Københaven N)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Lauren D McVey
Application Number: 29/629,852
Classifications
Current U.S. Class: Pulmonary (38) (D24/164)